Fate Therapeutics (FATE)

Some of the biggest catalysts for future growth in drug stocks include the millions of retiring baby boomers, and new innovative treatments for a variety of medical issues.

Fate Therapeutics GAAP EPS of -$0.19 beats by $0.47, revenue of $58.98M beats by $25.45M (NASDAQ:FATE)

From Seeking Alpha May 3, 2023

Fate Therapeutics press release (NASDAQ:FATE): Q1 GAAP EPS of -$0.19 beats by $0.47.Revenue of $58.98M (+220.5% Y/Y) beats by $25.45M.

Biotech ETF XBI drops to an 8-month low

From Seeking Alpha Mar 23, 2023

Fate Therapeutics GAAP EPS of -$0.58 beats by $0.29, revenue of $44.34M beats by $25.93M (NASDAQ:FATE)

From Seeking Alpha Feb 28, 2023

Fate Therapeutics press release (FATE): Q4 GAAP EPS of -$0.58 beats by $0.29.Revenue of $44.34M (+159.8% Y/Y) beats by $25.93M.Ended 2022 with Approximately $475 Million in Cash,...

How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?

From MarketBeat Jan 25, 2023

Five biotechs have already issued layoffs in 2023. Many seem to have good potential, but time will tell if the shifts create the value analysts anticipate.

Johnson & Johnson Breakout Breaks Down: Can Earnings Boost Stock?

From MarketBeat Jan 18, 2023

Johnson & Johnson stock has been struggling to break out of a correction. It formed a cup-shaped pattern that appeared to add a handle but broke down last week.

Fate Therapeutics (FATE) Gets a Buy from H.C. Wainwright

From TipRanks Nov 21, 2022

In a report released today, Robert Burns from H.C. Wainwright reiterated a Buy rating on Fate Therapeutics (FATE – Research Report), with a price target of $1...

Fate Therapeutics (FATE)

CRISPR Layoffs 2023: Job Cuts Hit Gene-Editing Stocks FATE, TCRR, IPSC

Why Is Fate Therapeutics (FATE) Stock Down 62% Today?

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

The 5 Top Stocks Cathie Wood Is Buying Now

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Fate Therapeutics (FATE)

11 Best Stocks to Buy for 2023

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

FATE Stock Predictions, Articles, and Fate Therapeutics News

Subscriber Sign in